Dedicated to helping people with life-threatening conditions through scientific innovations and excellence
Inhibrx develops multivalent costimulatory agonists, checkpoint inhibitors, and therapeutics to invert the tumor microenvironment toward local immune activation.
Challenges
| Difficulty finding data across multiple systems | Without a formal tracking system, plasmid maps were distributed across multiple scientists’ computers. Finding the right plasmid map would involve walking through the lab to find the right scientist. |
|---|---|
| Lack of data integrity | Spreadsheets were used to track requests and information about plasmids, requiring extensive manual search and limiting user compliance. |
| Tracking processes with paper | Experimental notes were taken using a shared paper lab notebook, making it difficult to find experimental details and extract insights. |
Outcomes
| Reliable registration | The Benchling Registry is a central source of truth for plasmids and enforces uniqueness constraints to ensure data integrity. |
|---|---|
| Interlinked experimental details | Scientists can link batches to relevant experiments, so their notes directly reflect all of the products and data they’ve generated. |
| Streamlined IND filing | Inhibrx uses Benchling Lab Notebook entries and unique Lab Notebook IDs to file for IND, saving months of time and effort. |
Powering breakthroughs for over 1,300 biotechnology companies, from startups to Fortune 500s
